In Vitro Human Immunodeficiency Virus Type 1 Resistance Selections With Combinations of Tenofovir and Emtricitabine or Abacavir and Lamivudine
Antimicrobial Agents and Chemotherapy- United States
doi 10.1128/aac.00816-06
Full Text
Abstract
Available in
Date
September 18, 2006
Authors
Publisher
American Society for Microbiology